Upstream Bio (UPB) Interest & Investment Income (2023 - 2026)

Upstream Bio's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 35.61% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $10.7 million (down 15.65% YoY), while the FY2025 annual figure was $16.9 million, up 39.68% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $3.1 million, down from $3.7 million in the prior quarter.
• The five-year high for Interest & Investment Income was $5.1 million in Q4 2024, with the low at -$110000.0 in Q2 2025.
• The 4-year median for Interest & Investment Income is $2.9 million (2024), against an average of $2.4 million.
• Peak annual rise in Interest & Investment Income reached 11392.86% in 2025, while the deepest fall reached 223.53% in 2025.
• Upstream Bio's Interest & Investment Income stood at $1.5 million in 2023, then soared by 234.17% to $5.1 million in 2024, then dropped by 28.01% to $3.7 million in 2025, then declined by 16.42% to $3.1 million in 2026.
• Business Quant data shows UPB's Interest & Investment Income at $3.1 million in Q1 2026, $3.7 million in Q4 2025, and $4.1 million in Q3 2025.